Glucose biosensors are devices that measure the concentration of glucose in diabetic patients by means of sensitive protein that relays the concentration by means of fluorescence, an alternative to amperometric sension of glucose.
Increasing incidence of diabetes across the globe is expected to be a key factor driving market growth. Diabetes is one of the most commonly occurring diseases worldwide. It is expected to be one of the leading causes of mortality all over the world.

The global Glucose Biosensor market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Glucose Biosensor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glucose Biosensor market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Glucose Biosensor in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Glucose Biosensor manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Roche
Bayer
LifeScan
Abbott
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Classical glucose enzyme electrode
Transfer medium sensor
Direct sensor

Segment by Application
Hospitals
Homecare Diagnostics
Research Institutes
Diagnostic Centers
Clinics